Autopsy and Case Reports
https://autopsyandcasereports.org/article/doi/10.4322/acr.2021.278
Autopsy and Case Reports
Autopsy Case Report

De novo double-hit B-cell precursor leukemia/lymphoma - an unusual presentation as peritoneal lymphomatosis

Balamurugan Thirunavukkarasu; Jayanta Samanta; Prateek Bhatia; Amanjit Bal

Downloads: 0
Views: 203

Abstract

Peritoneal lymphomatosis (PL) is a rare presentation of extranodal precursor leukemia/lymphoma. The presentation is often non-specific, leading to delayed diagnosis and treatment. In this case, though the preliminary diagnosis was established on ascitic fluid cytology, the disease progressed rapidly, leading to demise before initiating chemotherapy. Immunophenotyping and molecular studies, performed later, established a diagnosis of de novo B-cell precursor leukemia/lymphoma with MYC, BCL2 rearrangements (Double-hit lymphoma). MYC, BCL2 rearrangements are rarely reported in precursor B-lymphoma/leukemia which carry dismal prognosis. In this report, we illustrate autopsy findings of PL in an elderly gentleman who presented with ascites for evaluation.

Keywords

Precursor B-Cell Lymphoblastic Lymphoma, Peritoneal neoplasms, c-myc, Ascites

References

1 Weng S-C, Wu C-Y. Lymphoma presenting as peritoneal lymphomatosis with ascites. J Chin Med Assoc. 2008;71(12):646-50. http://dx.doi.org/10.1016/S1726-4901(09)70009-7. PMid:19114331.

2 Flores E, Aydin N, Vu D, Misra S. A case series of diffuse large B-cell lymphoma and burkitt lymphoma presenting with peritoneal lymphomatosis. Int J Surg Case Rep. 2016;28:262-5. http://dx.doi.org/10.1016/j.ijscr.2016.10.007. PMid:27756028.

3 Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375-90. http://dx.doi.org/10.1182/blood-2016-01-643569. PMid:26980727.

4 Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein HTJ, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Lyon; 2017.

5 Stratmann JA, von Rose AB, Koschade S, et al. Clinical and genetic characterization of de novo double-hit B cell precursor leukemia/lymphoma. Ann Hematol. 2019;98(3):647-56. http://dx.doi.org/10.1007/s00277-018-03590-x. PMid:30613837.

6 Krol ADG, le Cessie S, Snijder S, Kluin-Nelemans JC, Kluin PM, Noordijk EM. Primary extranodal non-Hodgkin’s lymphoma (NHL): the impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry. Ann Oncol. 2003;14(1):131-9. http://dx.doi.org/10.1093/annonc/mdg004. PMid:12488305.

7 Sia DSY, Kapur J, Thian YL. Peritoneal lymphomatosis mimicking peritoneal carcinomatosis: important imaging clues for correct diagnosis. Singapore Med J. 2013;54(4):e93-6. http://dx.doi.org/10.11622/smedj.2013091. PMid:23624464.

8 Lynch MA, Cho K, Jeffrey R Jr, Alterman D, Federle M. CT of peritoneal lymphomatosis. AJR Am J Roentgenol. 1988;151(4):713-5. http://dx.doi.org/10.2214/ajr.151.4.713. PMid:3262271.

9 Hoeller S, Copie-Bergman C. Grey zone lymphomas: lymphomas with intermediate features. Adv Hematol. 2012;2012:460801. http://dx.doi.org/10.1155/2012/460801.

10 Agarwal R, Lade S, Liew D, et al. Role of immunohistochemistry in the era of genetic testing in MYC-positive aggressive B-cell lymphomas: a study of 209 cases. J Clin Pathol. 2016;69(3):266-70. http://dx.doi.org/10.1136/jclinpath-2015-203002. PMid:26307073.

11 Ok CY, Medeiros LJ. High-grade B-cell lymphoma: a term re-purposed in the revised WHO classification. Pathology. 2020;52(1):68-77. http://dx.doi.org/10.1016/j.pathol.2019.09.008. PMid:31735344.

12 Secchi R, Meconi F, Esposito F, et al. B-Cell precursor acute lymphoblastic leukemia/lymphoma with MYC and BCL-2 rearrangements, a case report of an unclassified “New” entity. Ann Hematol Oncol. 2020;7(5):1302.

13 Kelemen K, Holden J, Johnson LJ, Davion S, Robetorye RS. Immunophenotypic and cytogenetic findings of B-lymphoblastic leukemia/lymphoma associated with combined IGH/BCL2 and MYC rearrangement. Cytometry B Clin Cytom. 2017;92(4):310-4. http://dx.doi.org/10.1002/cyto.b.21334.

14 Uchida A, Isobe Y, Uemura Y, et al. De novo acute lymphoblastic leukemia-like disease of high grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: a case report and literature review. BMC Clin Pathol. 2017;17(1):21. http://dx.doi.org/10.1186/s12907-017-0060-1. PMid:29151814.

15 Ok CY, Medeiros LJ, Thakral B, et al. High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma. Mod Pathol. 2019;32(1):48-58. http://dx.doi.org/10.1038/s41379-018-0112-9. PMid:30181564.

16 Kathiravan M, Singh M, Bhatia P, et al. Deletion of CDKN2A/B is associated with inferior relapse free survival in pediatric B cell acute lymphoblastic leukemia. Leuk Lymphoma. 2019;60(2):433-41. http://dx.doi.org/10.1080/10428194.2018.1482542. PMid:29966470.

17 Kaplan A, Samad A, Dolan MM, et al. Follicular lymphoma transformed to “double-hit” B lymphoblastic lymphoma presenting in the peritoneal fluid. Diagn Cytopathol. 2013;41(11):986-90. http://dx.doi.org/10.1002/dc.22871. PMid:22623514.

18 Yamamoto K, Kawamoto S, Kitao A, et al. Double-hit pancreatic B-lymphoblastic lymphoma with a variant translocation t(2;18)(p11;q21). Int J Hematol. 2019;110(1):107-14. http://dx.doi.org/10.1007/s12185-019-02646-6. PMid:30963474.

19 Chen Y-B, Rahemtullah A, Hochberg E. Primary effusion lymphoma. Oncologist. 2007;12(5):569-76. http://dx.doi.org/10.1634/theoncologist.12-5-569. PMid:17522245.

20 Friedberg JW. How I treat double-hit lymphoma. Blood. 2017;130(5):590-6. http://dx.doi.org/10.1182/blood-2017-04-737320. PMid:28600333.
 


Submitted date:
01/15/2021

Accepted date:
03/16/2021

Publication date:
05/06/2021

60944e21a953954741575fe3 autopsy Articles
Links & Downloads

Autops Case Rep

Share this page
Page Sections